Dinesh Chandra Doval

Efficacy and Safety of Lapatinib As First-Line Therapy for ErbB2-Amplified Locally Advanced or Metastatic Breast Cancer

Henry Gómez, Dinesh Chandra Doval, Miguel A. Chavez et al. · Journal of Clinical Oncology · 2008 · 340 citations · Full text

Multicenter Phase II Trial of ABI-007, an Albumin-Bound Paclitaxel, in Women With Metastatic Breast Cancer

Nuhad K. Ibrahim, Brian L. Samuels, Ray D. Page et al. · Journal of Clinical Oncology · 2005 · 270 citations

A Phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer

Dinesh Chandra Doval, Jagdev Singh Sekhon, Sunil K. Gupta et al. · British Journal of Cancer · 2004 · 136 citations · Full text

A phase II study of sunitinib as a second-line treatment in advanced biliary tract carcinoma: A multicentre, multinational study

Jun Yi, Sumitra Thongprasert, Dinesh Chandra Doval et al. · European Journal of Cancer · 2011 · 119 citations

Second-line Treatment, Medicine, Hepatobiliary Tumor +9

First-line gemcitabine versus epirubicin in postmenopausal women aged 60 or older with metastatic breast cancer: a multicenter, randomized, phase III study

Olavo Feher, P Vodvářka, Jacek Jassem et al. · Annals of Oncology · 2005 · 93 citations

Metastatic Breast Cancer, Oncology, Breast Oncology +8